| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Association of GSTM1 and GSTT1 deletion polymorphisms with Pakistani aplastic anemia patients and controls and meta-analysis
|
Rehman, Sadia
|
|
2015
|
94 |
12 |
p. 1965-1971
|
article
|
| 2 |
Clinical impact of hematogones on outcomes of allogeneic hematopoietic stem cell transplantation
|
Doki, Noriko
|
|
2015
|
94 |
12 |
p. 2055-2060
|
article
|
| 3 |
Decitabine versus best supportive care in older patients with refractory anemia with excess blasts in transformation (RAEBt) - results of a subgroup analysis of the randomized phase III study 06011 of the EORTC Leukemia Cooperative Group and German MDS Study Group (GMDSSG)
|
Becker, Heiko
|
|
2015
|
94 |
12 |
p. 2003-2013
|
article
|
| 4 |
Diverse phenotypes and transfusion requirements due to interaction of β-thalassemias with triplicated α-globin genes
|
Mehta, Pallavi R.
|
|
2015
|
94 |
12 |
p. 1953-1958
|
article
|
| 5 |
Early postnatal diagnosis of hereditary spherocytosis by combining light microscopy, acidified glycerol lysis test and eosin-5′-maleimide binding assay
|
Andres, Oliver
|
|
2015
|
94 |
12 |
p. 1959-1964
|
article
|
| 6 |
Efficacy and safety of the thrombopoietin receptor agonist romiplostim in patients aged ≥65 years with immune thrombocytopenia
|
Michel, Marc
|
|
2015
|
94 |
12 |
p. 1973-1980
|
article
|
| 7 |
Enhanced formation of neutrophil extracellular traps in patients with graft versus host disease
|
Qiao, Jianlin
|
|
2015
|
94 |
12 |
p. 2081-2083
|
article
|
| 8 |
Evaluation of IDH1G105 polymorphism as prognostic marker in intermediate-risk AML
|
Fasan, Annette
|
|
2015
|
94 |
12 |
p. 1991-2001
|
article
|
| 9 |
Hyperleukocytosis in acute myeloid leukemia patients is associated with high 30-day mortality which is not improved with leukapheresis
|
Wong, Gee Chuan
|
|
2015
|
94 |
12 |
p. 2067-2068
|
article
|
| 10 |
Idarubicin and cytarabine in combination with gemtuzumab ozogamicin (IAGO) for untreated patients with high-risk MDS or AML evolved from MDS: a phase II study from the EORTC and GIMEMA Leukemia Groups (protocol 06013)
|
Witte, Theo de
|
|
2015
|
94 |
12 |
p. 1981-1989
|
article
|
| 11 |
Impact of unbalanced minor route versus major route karyotypes at diagnosis on prognosis of CML
|
Fabarius, Alice
|
|
2015
|
94 |
12 |
p. 2015-2024
|
article
|
| 12 |
Lack of survival improvement with novel anti-myeloma agents for patients with multiple myeloma and central nervous system involvement: the Greek Myeloma Study Group experience
|
Katodritou, Eirini
|
|
2015
|
94 |
12 |
p. 2033-2042
|
article
|
| 13 |
Late occurrence of Epstein-Barr virus-associated lymphoproliferative disorder in a patient with follicular lymphoma treated with bendamustine and rituximab
|
Muroi, Kei
|
|
2015
|
94 |
12 |
p. 2061-2062
|
article
|
| 14 |
Lower gastrointestinal bleeding in a patient with Crohn’s disease and plasma cell leukemia in remission
|
Schrenk, Karin G.
|
|
2015
|
94 |
12 |
p. 2063-2065
|
article
|
| 15 |
Low levels of CD9 coincidental with a novel nonsense mutation in glycoprotein Ibβ in a patient with Bernard-Soulier syndrome
|
Qiao, Jianlin
|
|
2015
|
94 |
12 |
p. 2069-2071
|
article
|
| 16 |
Oral beclomethasone dipropionate as an initial treatment for stages 1–2 gastrointestinal tract acute graft-versus-host disease following unrelated cord blood transplantation
|
Yamamoto, Hisashi
|
|
2015
|
94 |
12 |
p. 2073-2075
|
article
|
| 17 |
Phase II study of bendamustine combined with rituximab in relapsed/refractory mantle cell lymphoma: efficacy, tolerability, and safety findings
|
Czuczman, Myron S.
|
|
2015
|
94 |
12 |
p. 2025-2032
|
article
|
| 18 |
Safe utilization of ibrutinib with or without steroids in chronic lymphocytic leukemia patients with autoimmune hemolytic anemia
|
St. Bernard, Rosanne
|
|
2015
|
94 |
12 |
p. 2077-2079
|
article
|
| 19 |
Sarcopenia is an independent prognostic factor in male patients with diffuse large B-cell lymphoma
|
Nakamura, Nobuhiko
|
|
2015
|
94 |
12 |
p. 2043-2053
|
article
|
| 20 |
The long-term efficacy and tolerability of oral deferasirox for patients with transfusion-dependent β-thalassemia in Taiwan
|
Chang, Hsiu-Hao
|
|
2015
|
94 |
12 |
p. 1945-1952
|
article
|
Journal description